SPDR S&P Biotech ETF Rating $102.67 -0.97 (-0.93%) As of 11:55 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock SPDR S&P Biotech ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XBI Aggregate RatingModerate Buy 2.65Holdings in XBI have an aggregate rating of Moderate Buy based on 515 analyst ratings issued in the past year covering 25 companies (46.3% of the portfolio).XBI Aggregate Price Target$103.640.39% UpsideHigh Prediction$103.64Average Prediction$103.64Low Prediction$103.64Holdings in XBI have an aggregate price target of $103.64 and a range of $103.64 to $103.64 covering 25 companies (46.3% of the portfolio).XBI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 XBI Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.48%CRSPCRISPR Therapeutics$68.39-2.6%1.6571 of 5 stars2.42$71.50 4.6%192.07%MRNAModerna$26.99-2.0%4.3504 of 5 stars2.00$41.81 54.9%231.99%UTHRUnited Therapeutics$453.060.0%4.3557 of 5 stars2.67$449.57 -0.8%15Insider Trade1.99%ABBVAbbVie$233.56+1.5%4.6268 of 5 stars2.82$229.14 -1.9%28Trending News1.95%EXELExelixis$39.23-2.0%4.8499 of 5 stars2.63$44.42 13.2%24Positive News1.93%BIIBBiogen$153.71-0.2%4.5625 of 5 stars2.31$180.04 17.1%32Positive NewsAnalyst Forecast1.92%REGNRegeneron Pharmaceuticals$583.46-0.3%4.7579 of 5 stars2.79$817.67 40.1%29Positive News1.90%IONSIonis Pharmaceuticals$68.29-1.1%3.4284 of 5 stars2.74$75.29 10.3%19Analyst Forecast1.90%AMGNAmgen$295.02+0.3%4.5789 of 5 stars2.30$309.42 4.9%20Trending News1.87%VRTXVertex Pharmaceuticals$412.73+2.4%4.8342 of 5 stars2.62$493.81 19.6%29Positive News1.86%INSMInsmed$158.49+0.1%3.3183 of 5 stars2.86$149.06 -5.9%211.86%MDGLMadrigal Pharmaceuticals$433.50-2.0%4.3131 of 5 stars2.73$495.88 14.4%111.82%EXASExact Sciences$57.65+0.0%4.5202 of 5 stars2.83$68.71 19.2%24Analyst Forecast1.81%BMRNBioMarin Pharmaceutical$54.92-1.2%4.9535 of 5 stars2.55$92.95 69.2%221.81%RVMDRevolution Medicines$46.01-1.2%4.2961 of 5 stars2.93$74.64 62.2%151.79%BBIOBridgeBio Pharma$53.46-2.1%4.2205 of 5 stars2.89$63.94 19.6%181.78%INCYIncyte$86.62-0.7%4.5274 of 5 stars2.28$83.64 -3.4%18Positive News1.75%ALNYAlnylam Pharmaceuticals$454.99+0.7%4.0771 of 5 stars2.79$448.04 -1.5%29Analyst Upgrade1.72%NBIXNeurocrine Biosciences$136.75-1.9%4.7684 of 5 stars2.81$161.89 18.4%211.72%TGTXTG Therapeutics$36.71-0.1%4.3754 of 5 stars2.67$49.00 33.5%6Analyst ForecastAnalyst Revision1.71%GILDGilead Sciences$116.25+2.4%4.8965 of 5 stars2.90$117.17 0.8%29Positive News1.69%RNAAvidity Biosciences$45.73-1.0%2.4989 of 5 stars2.95$68.32 49.4%201.68%NTRANatera$168.83-0.9%2.8815 of 5 stars2.90$192.88 14.2%201.68%HALOHalozyme Therapeutics$65.31-2.5%4.6661 of 5 stars2.38$70.44 7.9%13Analyst Revision1.65%ROIVRoivant Sciences$16.260.0%3.5099 of 5 stars2.80$19.94 22.6%10 This page (NYSEARCA:XBI) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
